How to buy Apollo Endosurgery stock | $9.65

Apollo Endosurgery Inc is a medical devices business based in the US. Apollo Endosurgery shares (APEN) are listed on the NASDAQ and all prices are listed in US Dollars. Apollo Endosurgery employs 158 staff and has a trailing 12-month revenue of around 0.00.

Apollo Endosurgery stock price (NASDAQ: APEN)

Use our graph to track the performance of APEN stocks over time.

Apollo Endosurgery shares at a glance

• Key figures

Information last updated 2021-10-23.

Latest market close	$9.65
52-week range	$1.61 - $10.04
50-day moving average	$9.17
200-day moving average	$7.90
Wall St. target price	$14.25
PE ratio	N/A
Dividend yield	N/A (0%)
Earnings per share (TTM)	$-0.54

Buy Apollo Endosurgery shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

*Signup bonus information updated weekly.

Is it a good time to buy Apollo Endosurgery stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Apollo Endosurgery price performance over time

Historical closes compared with the close of $9.65 from 2021-10-25

1 week (2021-10-15)	N/A
1 month (2021-09-24)	3.54%
3 months (2021-07-26)	21.23%
6 months (2021-04-26)	69.00%

1 year (2020-10-26)	471.01%
2 years (2019-10-25)	229.35%
3 years (2018-10-26)	64.96%
5 years (2016-10-26)	216.39%

Apollo Endosurgery financials

Revenue TTM	$56.2 million
Gross profit TTM	$22.2 million
Return on assets TTM	-12.84%
Return on equity TTM	-509.6%
Profit margin	-24.44%
Book value	$0.10
Market capitalisation	$355.8 million

TTM: trailing 12 months

Shorting Apollo Endosurgery shares

There are currently 440,525 Apollo Endosurgery shares held short by investors – that's known as Apollo Endosurgery's "short interest". This figure is 27.9% up from 344,516 last month.

There are a few different ways that this level of interest in shorting Apollo Endosurgery shares can be evaluated.

Apollo Endosurgery's "short interest ratio" (SIR)

Apollo Endosurgery's "short interest ratio" (SIR) is the quantity of Apollo Endosurgery shares currently shorted divided by the average quantity of Apollo Endosurgery shares traded daily (recently around 165610.90225564). Apollo Endosurgery's SIR currently stands at 2.66. In other words for every 100,000 Apollo Endosurgery shares traded daily on the market, roughly 2660 shares are currently held short.

However Apollo Endosurgery's short interest can also be evaluated against the total number of Apollo Endosurgery shares, or, against the total number of tradable Apollo Endosurgery shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Apollo Endosurgery's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 Apollo Endosurgery shares in existence, roughly 20 shares are currently held short) or 0.0219% of the tradable shares (for every 100,000 tradable Apollo Endosurgery shares, roughly 22 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Apollo Endosurgery.

Find out more about how you can short Apollo Endosurgery stock.

Apollo Endosurgery share dividends

We're not expecting Apollo Endosurgery to pay a dividend over the next 12 months.

Have Apollo Endosurgery's shares ever split?

Apollo Endosurgery's shares were split on a 10:55 basis on 29 December 2016. So if you had owned 55 shares the day before before the split, the next day you'd have owned 10 shares. This wouldn't directly have changed the overall worth of your Apollo Endosurgery shares – just the quantity. However, indirectly, the new 450% higher share price could have impacted the market appetite for Apollo Endosurgery shares which in turn could have impacted Apollo Endosurgery's share price.

Apollo Endosurgery share price volatility

Over the last 12 months, Apollo Endosurgery's shares have ranged in value from as little as $1.61 up to $10.04. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Apollo Endosurgery's is 2.2298. This would suggest that Apollo Endosurgery's shares are significantly more volatile than the average for this exchange and represent a higher risk.

Apollo Endosurgery overview

Apollo Endosurgery, Inc. , a medical technology company, focuses on the design, development, and commercialization of medical devices. The company offers OverStitch and OverStitch Sx Endoscopic Suturing Systems that enable advanced endoscopic procedures by allowing physicians to place full thickness sutures and secure the approximation of tissue through a flexible endoscope. It also provides Orbera, an intragastric balloon system that reduces stomach capacity causing patients to consume less following the procedure, and delays gastric content emptying under the Orbera Intragastric Balloon System, BIB, and Orbera365 Managed Weight Loss System brands; and Orbera Coach, a digital and remotely delivered aftercare program. The company sells its products to medical services providers; and hospitals, outpatient surgical centers, clinics, and physicians in the United States, Brazil, Australia, and other European countries. Apollo Endosurgery, Inc. was founded in 2005 and is headquartered in Austin, Texas.

Frequently asked questions

What percentage of Apollo Endosurgery is owned by insiders or institutions?
Currently 14.881% of Apollo Endosurgery shares are held by insiders and 49.096% by institutions. How many people work for Apollo Endosurgery?
Latest data suggests 158 work at Apollo Endosurgery. When does the fiscal year end for Apollo Endosurgery?
Apollo Endosurgery's fiscal year ends in December. Where is Apollo Endosurgery based?
Apollo Endosurgery's address is: Building 1, Austin, TX, United States, 78746 What is Apollo Endosurgery's ISIN number?
Apollo Endosurgery's international securities identification number is: US03767D1081 What is Apollo Endosurgery's CUSIP number?
Apollo Endosurgery's Committee on Uniform Securities Identification Procedures number is: 03767D108